Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects-Reference-Cited by-同舟云学术

Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects

Published:2018-02 Issue:2 Volume:40 Page:322-332.e5
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Wu Xiaojie,Li Yunfei,Zhang Jing,Zhang Yingyuan,Yu Jicheng,Cao Guoying,Chen Yuancheng,Guo Beining,Shi Yaoguo,Huang Jun,Cao Yuran,Liu Xiaofang,Wu Jufang,Gordeev Mikhail Fedorovich,Yuan Hong,Wang Wen

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. In vivo antibacterial activity of MRX-I, a new oxazolidinone;Li;Antimicrobial Agents Chemother,2014

2. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus;Hayakawa;Infect Cont Hosp Epidemiol,2011

3. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus;Gould;J Antimicrob Chemother,2011

4. New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile;Gordeev;J Med Chem,2014

5. Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I;Huang;Int J Antimicrob Agents,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment;Infection;2024-05-08

2. Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens;Antimicrobial Agents and Chemotherapy;2024-04-03

3. Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities;European Journal of Medicinal Chemistry;2024-04

4. A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects;Antimicrobial Agents and Chemotherapy;2023-11-15

5. Simultaneous Determination of Contezolid and Its Metabolite M2 in Human Plasma and Cerebrospinal Fluid by Ultra-High-Performance Liquid Chromatography – Tandem Mass Spectrometry (UHPLC-MS/MS);Analytical Letters;2023-11-08